ANT-3310

N/A

Report date: 2024/09/12 09:59:02
QIDP

Base Information

Drug NameANT-3310
Drug Alias NameSBLi-AntabioANT-3310MEM-ANT3310
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyFrance
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAntabio SAS
China Registration ClassN/A

Develop Information

Active CompaniesAntabio SAS
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A